PlainRecalls
FDA Drug Low Class III Terminated

Bumetanide Tablets USP 0.5 mg. Rx Only, a) 100-count Bottle, b) 500-count Bottle, Sandoz Inc., Princeton, NJ 08540, NDC a) 0185-0128-01, b) 0185-0128-05

Reported: December 18, 2013 Initiated: November 6, 2013 #D-341-2014

Product Description

Bumetanide Tablets USP 0.5 mg. Rx Only, a) 100-count Bottle, b) 500-count Bottle, Sandoz Inc., Princeton, NJ 08540, NDC a) 0185-0128-01, b) 0185-0128-05

Reason for Recall

Failed Moisture Limit; Out of Specification (OOS) results were obtained for moisture content during stability testing at the 12 month time point, controlled room temperature conditions.

Details

Recalling Firm
Sandoz Inc
Units Affected
11,496 bottles (100 count) and 62 bottles (500 count)
Distribution
Nationwide
Location
Wilson, NC

Frequently Asked Questions

What product was recalled?
Bumetanide Tablets USP 0.5 mg. Rx Only, a) 100-count Bottle, b) 500-count Bottle, Sandoz Inc., Princeton, NJ 08540, NDC a) 0185-0128-01, b) 0185-0128-05. Recalled by Sandoz Inc. Units affected: 11,496 bottles (100 count) and 62 bottles (500 count).
Why was this product recalled?
Failed Moisture Limit; Out of Specification (OOS) results were obtained for moisture content during stability testing at the 12 month time point, controlled room temperature conditions.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 18, 2013. Severity: Low. Recall number: D-341-2014.